As part of Market Access Communications within Evidera’s Evidence Synthesis, Modeling & Communication team, Ann leads client engagements with a focus on supporting differentiating value propositions using clinical and economic evidence and communicating the value story to key stakeholders in an impactful way.
Previously, Ann served as a director of health economics and market access with DePuy Synthes, a Johnson & Johnson company. In this role, she led the development of global market access strategies for new product innovation as well as leading the US regional market access strategies for newly launched and existing products for the spine and trauma business units. Ann developed the global and US strategy and executed the tactical plan to support the full product lifecycle through evidence generation, economic modeling, dossier development (GVDs and value briefs), real-world evidence, and market access communications. She has extensive experience seeking advice from payers, providers (e.g., hospitals and ASCs), and surgeons through advisory boards to inform business strategies early in product development as well as near launch to refine value propositions and gather insights that shape the evidence communication strategies. She has presented research at international conferences and has published in journals such as Value in Health, Spine, Scientific World Journal, and Nucleic Acids Research. Prior to J&J, Ann worked at Vertex Pharmaceuticals as a senior manager of health economics. In this role she developed economic models, AMCP dossiers, and global HTA submissions. Ann also has deep knowledge of clinical and biotech research through leading clinical trials and conducting in vitro cellular research in prior roles with Zimmer, Biomet, and Mirus Bio (now part of Roche). She draws on her deep experience to provide clients with solutions that best fit the client’s needs based on product lifecycle stage and overall market access strategy to communicate value to the right stakeholder at the right time.
Ann earned an MS in genetics from the University of Wisconsin-Madison and holds a master’s certificate in health economics and outcomes research from Thomas Jefferson University, as well as a BS in microbiology from Indiana University-Bloomington.